AZGP1 and cancer: To investigate whether the target genes changed with cancer development, we performed a differential expression analysis between high- and low-grade cancer samples for all 9 datasets from Figure 4A. In particular, the zinc-binding genes (all six metallothioneins, AZGP1 and ANPEP) showed consistent downregulation in high-grade cancer (Table S7).